Earnings
Home›Earnings›Previews›Moderna shares surge after promising cancer-vaccine tr…
Moderna shares surge after promising cancer-vaccine trial update
Moderna’s stock jumped sharply after the company shared encouraging results tied to a cancer-vaccine approach.
MarketWatch reports the candidate combines an mRNA therapy with Keytruda, a cancer drug.
The update focused on pairing the mRNA platform with an existing oncology treatment, reflecting an effort to improve cancer outcomes through the combined regimen.
← Newer storyTreasury to double long-end liquidity support buyback size from Sept.…Older story →Amazon boosts northwest Louisiana data center spending to about $18B